AdvisorShares Pure US Cannabis ETF

MSOS
$4.62 +0.03 (0.65%)
Dividend Yield 1.52%
Payout Frequency Yearly

Dividend History

Pay DateAmountEx-DateRecord Date
December 31, 2021$0.072021-12-232021-12-27

Dividends Summary

Company News

Trump's Cannabis Rescheduling Order Could Finally Kill A Crushing Tax Rule And Transform US Weed Stocks, Says Expert
Benzinga • Rishabh Mishra • January 19, 2026

President Trump's executive order to reschedule cannabis to Schedule 3 could eliminate Section 280E of the Internal Revenue Code, allowing U.S. cannabis operators to deduct business expenses for the first time. This represents the most significant federal cannabis policy shift in over 50 years. However, challenges remain including inability to li...

Trump's Marijuana Order Is Lighting Up This Cannabis ETF: Momentum Score Spikes
Benzinga • Vishaal Sanjay • January 9, 2026

The AdvisorShares Pure U.S. Cannabis ETF (MSOS) is experiencing a significant momentum surge following the Trump administration's reclassification of marijuana. The ETF's Momentum score jumped from 24.75 to 88.95 in just over a week, driven by renewed industry optimism and strong earnings from Tilray Brands. The reclassification is expected to bo...

High Hopes: Pot Stocks Blaze As Trump Eyes Rescheduling
Benzinga • Erica Kollmann • December 17, 2025

President Trump is considering rescheduling marijuana from Schedule I to Schedule III, which could potentially remove tax burdens on cannabis businesses and improve their financial prospects.

Trump Weighs Marijuana Changes: 'A Lot Of People Want To See It'
Benzinga • Erica Kollmann • December 15, 2025

President Trump is considering an executive order to reclassify marijuana as a Schedule III substance, which could transform the cannabis market, reduce legal punishments, and facilitate scientific research.

1 Major Reason Cannabis Stocks Surged This Week
The Motley Fool • Patrick Sanders • October 1, 2025

Marijuana stocks experienced significant gains after Donald Trump's video promoting hemp-derived CBD benefits and potential marijuana reclassification, with several cannabis companies and ETFs seeing notable price increases.

Related Companies